Home
About
Overview
Sharing Data
ORCID
Help
History (13)
A dose escalation study of ORG 10172 (low molecular weight heparinoid) in stroke.
Clinical guidelines: blood pressure goals in T2DM: a Latin American perspective.
BCR-ABL1 compound mutations combining key kinase domain positions confer clinical resistance to ponatinib in Ph chromosome-positive leukemia.
Visit duration for outpatient physician office visits among patients with cancer.
Acceptable recipient outcomes with the use of hearts from donors with hepatitis-B core antibodies.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Acceptable recipient outcomes with the use of hearts from donors with hepatitis-B core antibodies.
Acceptable recipient outcomes with the use of hearts from donors with hepatitis-B core antibodies. J Heart Lung Transplant. 2005 Jan; 24(1):34-7.
View in:
PubMed
subject areas
Adult
Aged
Female
Heart Transplantation
Hepatitis B Antibodies
Hepatitis B Core Antigens
Hepatitis B, Chronic
Humans
Lamivudine
Male
Middle Aged
New York
Postoperative Complications
Retrospective Studies
Reverse Transcriptase Inhibitors
Survival Analysis
Treatment Outcome
authors with profiles
Sean Pinney